AMIX Autonomix Medical, Inc. Common Stock logo

AMIX Autonomix Medical, Inc. Common Stock

Healthcare
$0.40+0.00%ClosedMarket Cap: $2.1M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

0.42

P/S

0.00

EV/EBITDA

0.46

DCF Value

$4.81

FCF Yield

-524.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-228.8%

ROA

-168.8%

ROIC

-205.0%

Financials

View All
PeriodRevenueNet IncomeEPS
Q3 null$0.00$-3.3M$
Q2 null$0.00$-7.5M$
Q1 null$0.00$-3.3M$
Q4 null$0.00$-3.2M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Maxim GroupBuy
2026-02-17

Trading Activity

Insider Trades

View All
Smith Trent N.officer: CFO
SellWed Aug 13
Smith Trent N.officer: CFO
SellWed Aug 13
KLEMP WALTER Vdirector
SellWed Aug 13
Hauser Bradleyofficer: CEO and President
SellWed Aug 13
Capelli Christopherdirector
SellWed Aug 13

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

-1.80

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

Peers